Investigating the role of neutrophils in dengue virus infection

Grant number: 227193/Z/23/Z

Grant search

Key facts

  • Disease

    Dengue
  • Start & end year

    2022
    2025
  • Known Financial Commitments (USD)

    $0
  • Funder

    Wellcome Trust
  • Principal Investigator

    Mr. Isaac M Dowell
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Bristol
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Dengue is an emerging, endemic, mosquito-borne disease in tropical regions worldwide. It causes ~390 million infections and ~40,000 deaths per year. The severity of the disease varies from asymptomatic to fatal in different people, suggesting that an individual's susceptibility and immune responses play a significant role in patients' recovery. Neutrophils are a vital component of the immune system, comprising over 50% of white blood cells in the blood. However, what they do when a person gets dengue is poorly characterised. I aim to determine whether dengue virus can infect or activate neutrophils, how they respond, and how that changes the ability of the virus to infect cells and disease severity. I will analyse the proteins in patients' blood and neutrophils to identify proteins that may be important and will then investigate the role of these in the neutrophil response. I will assess the impact of these proteins on viral infectivity and vascular dysfunction, a symptom of severe dengue disease. This project will help explain the role neutrophils play in dengue infection and whether they have a detrimental effect that increases symptoms. This will be useful in developing new treatments and therapeutics that can help those infected by dengue virus.